Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

$317M

Market Cap • 7/7/2025

1995

(30 years)

Founded

2000

(25 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

The Woodlands

Headquarters • Texas